Related Experiment Video
Updated: Aug 18, 2026

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing (ChIP-seq)
Published on: April 19, 2013
No association between the deltaF508 cystic fibrosis mutation and type 2 diabetes mellitus
J Braun1, J Arnemann, M Lohrey
1Medical Clinic I, Department of Endocrinology, University of Frankfurt/Main, Germany.
Insights
Heterozygosity for the deltaF508 mutation, common in cystic fibrosis (CF), was investigated as a risk factor for type 2 diabetes. This study found no significant association, indicating deltaF508 is not a major genetic risk factor for type 2 diabetes.
Area of Science:
- Genetics and Human Health
- Metabolic Disorders
Background:
- Cystic fibrosis (CF) is a common inherited disorder caused by CFTR gene mutations.
- The deltaF508 mutation is the most prevalent CF mutation.
- Increased type 2 diabetes mellitus (T2DM) incidence in CF relatives suggests a potential genetic link.
Purpose of the Study:
- To investigate if heterozygosity for the deltaF508 mutation is a genetic risk factor for T2DM.
- To evaluate the prevalence of deltaF508 heterozygotes in T2DM patients and healthy controls.
Main Methods:
- Genotyping analysis was performed on 301 T2DM patients and 282 healthy controls.
- Patients with T2DM had received treatment for at least three years.
- Controls had no family history of diabetes.
Main Results:
- The genotype distribution of deltaF508 heterozygotes did not significantly differ between T2DM patients (2%) and controls (3%).
- These findings suggest a lack of association between deltaF508 heterozygosity and T2DM.
Conclusions:
- Heterozygosity for the deltaF508 mutation is not a major genetic risk factor for type 2 diabetes mellitus.
- Further research may explore other genetic or environmental factors contributing to T2DM in CF-related populations.
Abstract:
Cystic fibrosis (CF) is one of the most common recessively inherited disorders in Caucasian populations and is caused by mutations in the CF transmembrane conductance regulator (CFTR) gene. A three base deletion known as deltaF508 occurs on about 70%, of CF chromosomes and accounts for the high prevalence of the disease. Since type 2 diabetes mellitus occurs more frequently in relatives of patients with CF than in the normal population, we addressed the hypothesis whether heterozygosity for deltaF508 might be a genetic risk factor for type 2 diabetes. We screened 301 patients with type 2 diabetes mellitus which had been treated for at least three years from diagnosis by diet or oral antihyperglycemic agents. Healthy controls (n = 282) had no family history for diabetes. The genotype distribution did not differ significantly between patients with type 2 diabetes (2% heterozygotes) and controls (3% heterozygotes). According to these results, we conclude, that the deltaF508 mutation in its heterozygous form does not represent a major genetic risk factor for type 2 diabetes mellitus.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Type I Diabetes I: Introduction
Type I Diabetes II: Pathophysiology
Type II Diabetes I: Introduction
Type II Diabetes II: Pathophysiology
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

